Back to BlackRock, Inc. BlackRock, Inc.

VRCAVRCA
4 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in VERRICA PHARMACEUTICALS INC

Yes. BlackRock holds 74,344 shares of VRCA (Verrica Pharmaceuticals), worth $454,986, as of its Q2 2026 13F filing. It increased the position by 35,791 shares (+92.8%) from Q1 2026. BlackRock has held VRCA in every 13F on record since Q3 2025, 4 quarterly filings.

Current Value

$454,986

Current Shares

74,344

Total Value Change

+$428,488

Total Shares Change

+68,196

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
74,344
+92.8%
$454,9860.0%$6.12
26
2026-Q1
Increased
38,553
+578.1%
$203,9450.0%$5.12
25
2025-Q4
Decreased
5,685
-7.5%
$47,2430.0%$8.30
0
2025-Q3
New
6,148
-
$26,4980.0%$4.30
30

Other major holders of VRCA: VANGUARD CAPITAL MANAGEMENT LLC, Mariner, LLC, VANGUARD GROUP INC, TWO SIGMA INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used